Two months after saying it couldn't recommend Genmab's cervical cancer therapy Tivdak for use by the NHS, reimbursement ...

An unsolicited bid by private equity group CVC to take control of Italian pharma company Recordati looks likely to come off, ...

Biogen and Denali have now confirmed that the results show BIIB122 (also known as DNL151) did not slow the progression of ...

Galapagos' difficult year has continued with a decision to wind down its cell therapy business as it looks for deals that will deliver a "strong and sustainable future." The Belgian biotech's ...

Pfizer has upped the ante in the increasingly competitive market for pneumococcal vaccines with mid-stage clinical data for a ...

Eli Lilly's triple G agonist retatrutide has achieved weight loss of more than 28% in a new phase 3 trial that keeps it on course for regulatory filings later this year. The readout from the TRIUMPH-1 ...

A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata. In a brief filing with the National Stock Exchange (NSE) of ...

Bayer has filed to modify the label for its chronic kidney disease (CKD) Kerendia to include people with type 1 diabetes, ...

There is only one approved therapy for lung disease non-cystic fibrosis bronchiectasis (NCFB) in the US and Europe – Insmed's ...

The Singapore Court of Appeal has retained an injunction against KBP Bio and its founder, Dr Huang Zhenhua, and ruled that a lawsuit brought by Novo Nordisk will be taken to arbitration. Last year, ...

A 'hybrid' therapy for Parkinson's disease developed by Remepy, combining a drug with a digital therapeutic, has shown ...

UK-based GHO and CBC Group of Singapore – have announced a merger to create a massive player in the category with $21 billion ...